Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-020091
Filing Date
2022-08-11
Accepted
2022-08-11 16:01:46
Documents
50
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20220630_10q.htm   iXBRL 10-Q 939912
2 EXHIBIT 3.1 ex_409319.htm EX-3.1 103342
3 EXHIBIT 31.1 ex_378191.htm EX-31.1 15823
4 EXHIBIT 31.2 ex_378192.htm EX-31.2 15400
5 EXHIBIT 32.1 ex_378193.htm EX-32.1 8599
  Complete submission text file 0001437749-22-020091.txt   4367961

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA wint-20220630.xsd EX-101.SCH 39500
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20220630_cal.xml EX-101.CAL 28401
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20220630_def.xml EX-101.DEF 274800
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20220630_lab.xml EX-101.LAB 255535
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20220630_pre.xml EX-101.PRE 290204
44 EXTRACTED XBRL INSTANCE DOCUMENT wint20220630_10q_htm.xml XML 555697
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39290 | Film No.: 221155547
SIC: 2836 Biological Products, (No Diagnostic Substances)